Jakob Dorler
Overview
Explore the profile of Jakob Dorler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bergler-Klein J, Rainer P, Wallner M, Zaruba M, Dorler J, Bohmer A, et al.
Wien Klin Wochenschr
. 2022 May;
134(17-18):654-674.
PMID: 35507087
Survival in cancer is continuously improving due to evolving oncological treatment. Therefore, cardiovascular short-term and long-term side effects gain crucial importance for overall outcome. Cardiotoxicity not only presents as heart...
2.
Hasun M, Dorler J, Alber H, Bauer A, Berger R, Christ G, et al.
Cardiovasc Diagn Ther
. 2021 Jul;
11(3):726-735.
PMID: 34295699
Background: Randomised controlled trials have shown diverse results for radial access in patients undergoing primary percutaneous coronary intervention (PPCI). Moreover, it is questionable whether radial access improves outcome in patients...
3.
Bonderman D, Polzl G, Ablasser K, Agis H, Aschauer S, Auer-Grumbach M, et al.
Wien Klin Wochenschr
. 2020 Dec;
132(23-24):742-761.
PMID: 33270160
The prevalence and significance of cardiac amyloidosis have been considerably underestimated in the past; however, the number of patients diagnosed with cardiac amyloidosis has increased significantly recently due to growing...
4.
De Luca L, Zeymer U, Claeys M, Dorler J, Erne P, Matter C, et al.
Eur Heart J Cardiovasc Pharmacother
. 2020 Jan;
7(2):94-103.
PMID: 31965164
Aims: Among acute coronary syndromes (ACS), ST-segment elevation myocardial infarction (STEMI) has the most severe early clinical course. Recent randomized clinical trials have demonstrated that novel antithrombotic therapies improve in-hospital...
5.
Ammenwerth E, Modre-Osprian R, Fetz B, Gstrein S, Krestan S, Dorler J, et al.
JMIR Cardio
. 2019 Nov;
2(1):e11.
PMID: 31758765
Background: Heart failure is a major health problem associated with frequent hospital admissions. HerzMobil Tirol is a multidisciplinary postdischarge disease management program for heart failure patients to improve quality of...
6.
Wanitschek M, Edlinger M, Dorler J, Alber H
BMJ Open
. 2018 Jun;
8(6):e021808.
PMID: 29880572
Purpose: The Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort is aimed to gain a better understanding of cardiovascular risk factors and their relation to the...
7.
Burghard P, Plank F, Beyer C, Muller S, Dorler J, Zaruba M, et al.
Eur Radiol
. 2018 Jun;
28(12):5129-5136.
PMID: 29869175
Objectives: To evaluate right ventricle (RV) function by coronary computed tomography angiography (CTA) using a novel automated three-dimensional (3D) RV volume segmentation tool in comparison with clinical reference modalities. Methods:...
8.
Edlinger M, Dorler J, Ulmer H, Wanitschek M, Steyerberg E, Alber H, et al.
Int J Cardiol
. 2018 Jun;
267:8-12.
PMID: 29853277
No abstract available.
9.
Messner M, Ghadge S, Goetsch V, Wimmer A, Dorler J, Polzl G, et al.
PLoS One
. 2018 Apr;
13(4):e0196739.
PMID: 29702688
Background: Mutations in the LMNA gene are a common cause (6-8%) of dilated cardiomyopathy (DCM) leading to heart failure, a growing health care problem worldwide. The premature aging disease Hutchinson-Gilford...
10.
Hasun M, Dorler J, Edlinger M, Alber H, von Lewinski D, Eber B, et al.
Am J Cardiol
. 2017 Nov;
120(12):2135-2140.
PMID: 29103603
Randomized controlled trials have shown conflicting results regarding the outcome of bivalirudin in primary percutaneous coronary intervention (PPCI). The aim of this study was to evaluate the in-hospital outcomes of...